.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Mallinckrodt
Fish and Richardson
McKinsey
Julphar
AstraZeneca
Dow
Cantor Fitzgerald
Express Scripts

Generated: February 19, 2018

US Patents Corresponding to PCT: WO2009/098169


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Citius PharmsSUPRENZAphentermine hydrochlorideTABLET, ORALLY DISINTEGRATING;ORAL202088-001Jun 13, 2011DISCNNoNo➤ Sign Up➤ Sign UpY
Citius PharmsSUPRENZAphentermine hydrochlorideTABLET, ORALLY DISINTEGRATING;ORAL202088-002Jun 13, 2011DISCNNoNo➤ Sign Up➤ Sign UpY
Citius PharmsSUPRENZAphentermine hydrochlorideTABLET, ORALLY DISINTEGRATING;ORAL202088-003Mar 27, 2012DISCNNoNo➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist